Literature DB >> 23890832

Prevalence of modifiable surgical site infection risk factors in hip and knee joint arthroplasty patients at an urban academic hospital.

Jason S Pruzansky1, Michael J Bronson2, Ronald P Grelsamer2, Elton Strauss2, Calin S Moucha2.   

Abstract

Surgical site infections after hip and knee arthroplasty can be devastating if they lead to periprosthetic joint infection. We examined the prevalence of the modifiable risk factors for surgical site infection described by the American Academy of Orthopaedic Surgery Patient Safety Committee. Our study of 300 cases revealed that only 20% of all cases and 7% of revision cases for infection had no modifiable risk factors. The most common risk factors were obesity (46%), anemia (29%), malnutrition (26%), and diabetes (20%). Cases with obesity or diabetes were associated with all histories of remote orthopedic infection, 89% of urinary tract infections, and 72% of anemia cases. The high prevalence of several modifiable risk factors demonstrates that there are multiple opportunities for perioperative optimization of such comorbidities.
© 2013.

Entities:  

Keywords:  epidemiology; hip arthroplasty; infection; knee arthroplasty; risk factors

Mesh:

Year:  2013        PMID: 23890832     DOI: 10.1016/j.arth.2013.06.019

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  26 in total

Review 1.  Prosthetic Joint Infections: an Update.

Authors:  C L Abad; A Haleem
Journal:  Curr Infect Dis Rep       Date:  2018-05-22       Impact factor: 3.725

2.  CORR Insights®: Do various factors affect the frequency of manipulation under anesthesia after primary total knee arthroplasty?

Authors:  Michael J Bronson
Journal:  Clin Orthop Relat Res       Date:  2014-07-31       Impact factor: 4.176

3.  Do glycemic markers predict occurrence of complications after total knee arthroplasty in patients with diabetes?

Authors:  Ji Sup Hwang; Seok Jin Kim; Ankur B Bamne; Young Gon Na; Tae Kyun Kim
Journal:  Clin Orthop Relat Res       Date:  2014-11-18       Impact factor: 4.176

4.  Risk factors for infection, revision, death, blood transfusion and longer hospital stay 3 months and 1 year after primary total hip or knee arthroplasty.

Authors:  Chanseok Rhee; Lynn Lethbridge; Glen Richardson; Michael Dunbar
Journal:  Can J Surg       Date:  2018-06       Impact factor: 2.089

5.  Clinical results of revision total elbow arthroplasty: comparison of infected and non-infected total elbow arthroplasty.

Authors:  Jae-Man Kwak; Erica Kholinne; Yucheng Sun; Myung-Sun Kim; Kyoung-Hwan Koh; In-Ho Jeon
Journal:  Int Orthop       Date:  2019-01-07       Impact factor: 3.075

6.  Common Medical Comorbidities Correlated With Poor Outcomes in Hip Periprosthetic Infection.

Authors:  Daniel J Cunningham; Joseph J Kavolus; Michael P Bolognesi; Samuel S Wellman; Thorsten M Seyler
Journal:  J Arthroplasty       Date:  2017-03-31       Impact factor: 4.757

7.  Inadequate pre-operative glycaemic control in patients with diabetes mellitus adversely influences functional recovery after total knee arthroplasty : Patients with impaired glycaemic control exhibit poorer functional outcomes at 1-year post-arthroplasty.

Authors:  Timothy M Brock; Mark Shirley; Michelle Bardgett; Mark Walker; David J Deehan
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-08-08       Impact factor: 4.342

Review 8.  The Influence of Obesity on the Outcome of TKR: Can the Impact of Obesity be justified from the Viewpoint of the Overall Health Care System?

Authors:  E Carlos Rodriguez-Merchan
Journal:  HSS J       Date:  2014-04-05

9.  Hip and knee arthroplasty implants contraindicated in obesity.

Authors:  J D Craik; M D Bircher; M Rickman
Journal:  Ann R Coll Surg Engl       Date:  2016-03-29       Impact factor: 1.891

10.  Short-term Follow-up of Antibiotic-loaded Articulating Cement Spacers in Two-stage Revision of Infected Total Knee Arthroplasty: A Case Series.

Authors:  Meng-Qiang Tian; Xian-Teng Yang; Xiao-Bin Tian; Yun-Bo Sun; Yuan-Hui Duan; Li Sun
Journal:  Orthop Surg       Date:  2018-05-17       Impact factor: 2.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.